Emergent Health Corp - EMGE

EMGE Returns vs S&P 500 ⓘ

ticker	1 day return %	1 week return %	1 month return %	3 months return %	6 months return %	1 year return %	3 years return %	5 years return %	10 years return %	maximum return %
EMGE	-27.3	-11.1	-20	-33.3	-66.7	14.3	-98	-99.1	-99.9	-100.0
S&P 500	0.8	1.7	2.9	4.3	9.6	25.8	38.3	83.6	195.7	34441.3

Compare EMGE with other assets →

Returns Charts ⓘ

Interactive Price Chart

Our interactive price chart includes various drawing tools to help you analyze the product more effectively. Below is a quick guide on how to use these tools: Full Guideline

Real-time Full Quote

Attribute	Value
symbol	EMGE
name	Emergent Health Corp
price	0.0008
changes percentage	-27.2727
change	-0.0003
day low	0.0008
day high	0.0008
year high	0.0041
year low	0.0007
market cap	33544
price avg 50	0.00094
price avg 200	0.001448
exchange	PNK
volume	3400
avg volume	461962
open	0.0008
previous close	0.0011
eps	-0.007
pe	-0.11
earnings announcement	None
shares outstanding	41930000
timestamp	2025-01-22 16:37:45

Financial Statements ⓘ

We derive the score of a company's financial statements by evaluating the weighted average sentiment across key within the statements. The cumulative score, normalized to a sum of 1, serves as a metric for assessing the company's performance during the specified period. A higher score indicates stronger performance. However, it's crucial to note that while this score provides valuable insights, it is just one of many factors to consider when making informed investment decisions. A holistic evaluation, considering various aspects of the company's financial health and market conditions, is essential for a well-rounded investment strategy.

Overall Annual Financial Health: 42.3%

Overall Quarterly Financial Health: 11.0%

Income Statements ⓘ

• Annual Income Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001463459
revenue	1635026	574613	184.54
gross profit	1038154	127639	713.35
gross profit ratio	0.63	0.22	185.84
research and development expenses	27574	8586	221.15
operating expenses	2445986	1883700	29.85
interest income	0	8750	-100.00
interest expense	220133	361528	-39.11
ebitda	-1387832	-1727311	19.65
ebitdaratio	-0.85	-3.02	71.91
operating income	-1407830	-1756060	19.83
operating income ratio	-0.86	-3.06	71.83
net income	-1628073	-2107450	22.75
net income ratio	-1.0	-3.67	72.85
eps	-0.0	-0.01	50.62

Overall Score of Annual Income Statement

0.25 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Revenue Growth: revenue decreased to 2 million in 2023 from 1 million in 2022 representing a change of 184.54%. This indicates a sales shrinking, which is a negative sign for the company.

  Research and Development (R&D) Expenses: R&D Expenses decreased to 0 million in 2023 from 0 million in 2022 representing a change of 221.15%. This shows that the company decreased investment in innovation and product development, which is not a good sign for long-term growth.

  Operating Expenses: Operating Expenses increased to 2 million in 2023 from 2 million in 2022 representing a change of 29.85%. The increase in operating expenses can be attributed to various factors such as marketing, administrative costs, and investments in infrastructure. It's important to monitor if these expenses are growing at a sustainable rate compared to revenue.

  EBITDA: EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) decreased to -1 million in 2023 from -2 million in 2022 representing a change of 19.65%. The decrease in EBITDA indicates declined operational efficiency and profitability.

  Operating Income: Operating income decreased to -1 million in 2023 from -2 million in 2022 representing a change of 19.83%. The decrease in operating income indicates worse operational performance and decreased profitability.

  Net Income: Net income decreased to -2 million in 2023 from -2 million in 2022 representing a change of 22.75%. The decrease in net income shows worsen profitability and indicates that the company is generating less profit for each dollar of revenue.

• 📈 Positive Indicators

  Gross Profit: Gross Profit increased to 1 million in 2023 from 0 million in 2022 representing a change of 713.35%. This indicates a sales profitability growth, which is a positive sign for the company.

  Earnings per Share (EPS): EPS increased to -0.0 in 2023 from -0.0 in 2022 representing a change of 50.62%. This indicates that the company's earnings are increasing and it is becoming more profitable on a per-share basis.

• Quarterly Income Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001463459
revenue	-460658	460658	-200.00
gross profit	-289657	289657	-200.00
gross profit ratio	0.63	0.63	0.00
research and development expenses	3345	4043.0	-17.26
operating expenses	-439883	641140	-168.61
interest income	0	0	NaN
interest expense	59565	62301	-4.39
ebitda	155226	-346483	144.80
ebitdaratio	-0.34	-0.75	55.20
operating income	150226	-351480	142.74
operating income ratio	-0.33	-0.76	57.26
net income	90661	-413784	121.91
net income ratio	-0.2	-0.9	78.09
eps	0.0	-0.0	120.00

Overall Score of Quarterly Income Statement

None

Detailed Analysis

Balance Sheets ⓘ

• Annual Balance Sheet

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001463459
total assets	533701	790213	-32.46
total liabilities	2886062	1849589	56.04
total equity	-2352361	-1059376	-122.05
cash and cash equivalents	24866	13258	87.55
short term investments	334390	334390	0.00
long term investments	0	0	NaN
total current assets	396136	632648	-37.38
total non current assets	137565	157565	-12.69
total current liabilities	2886062	1849589	56.04
total non current liabilities	2482809	0	NaN
common stock	426951	260851	63.68
retained earnings	-4934596	-3306523	-49.24
total debt	2482810	1661900	49.40

Overall Score of Annual Balance Sheet

0.22 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Total Assets: Total Assets decreased to 1 million in 2023 from 1 million in 2022 representing a change of -32.46%. Suggesting a decrease in asset holdings.

  Total Liabilities: Total Liabilities increased to 3 million in 2023 from 2 million in 2022 representing a change of 56.04%. This indicates an increase in overall liabilities.

  Total Equity: Total Equity decreased to -2 million in 2023 from -1 million in 2022 representing a change of -122.05%. This indicates a decrease in shareholders' equity.

  Total Current Assets: Total Current Assets decreased to 0 million in 2023 from 1 million in 2022 representing a change of -37.38%. This indicates a worsen liquidity position.

  Total Current Liabilities: Total Current Liabilities increased to 3 million in 2023 from 2 million in 2022 representing a change of 56.04%. This indicates a higher short-term debt burden.

  Retained Earnings: Retained Earnings decreased to -5 million in 2023 from -3 million in 2022 representing a change of -49.24%. This indicates an accumulated losses.

  Total Debt: Total Debt increased to 2 million in 2023 from 2 million in 2022 representing a change of 49.4%. This indicates an increase in overall debt burden.

• 📈 Positive Indicators

  Cash And Cash Equivalents: Cash And Cash Equivalents increased to 0 million in 2023 from 0 million in 2022 representing a change of 87.55%. This indicates an increase in available liquid assets.

  Common Stock: Common Stock increased to 0 in 2023 from 0 in 2022 representing a change of 63.68%. This indicates an increase in ownership interest.

• Quarterly Balance Sheet

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001463459
total assets	155356	624284	-75.11
total liabilities	3249700	3390429	-4.15
total equity	-3094343	-2766145	-11.86
cash and cash equivalents	123.0	47193	-99.74
short term investments	1880	334390	-99.44
long term investments	0	0	NaN
total current assets	79291	491719	-83.87
total non current assets	76065	132564	-42.62
total current liabilities	3249700	3390429	-4.15
total non current liabilities	0	0	NaN
common stock	426951	426951	0.00
retained earnings	-5676578	-5348380	-6.14
total debt	2600269	2917535	-10.87

Overall Score of Quarterly Balance Sheet

None

Detailed Analysis

Cashflow Statements ⓘ

• Annual Cashflow Statement

Note: The years below are fiscal years in accounting.

	2023	2022	Y/Y change %
0001463459
net change in cash	11608	-244504	104.75
operating cash flow	-1219802	-1896079	35.67
free cash flow	-1219800	-1946079	37.32
capital expenditure	2	-50000	100.00
depreciation and amortization	20000	20000	0.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts payables	68030	178651	-61.92
inventory	0	69618	-100.00
acquisitions net	0	0	NaN
investments in property plant and equipment	2	-50000	100.00
net cash used for investing activites	160000	-634390	125.22
debt repayment	820910	1299237	-36.82
common stock issued	250500	1004447	-75.06
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	1071410	2303684	-53.49
cash at end of period	24866	13258	87.55
accounts receivables	0	0	NaN
cash at beginning of period	13258	257762	-94.86

Overall Score of Annual Cashflow Statement

0.8 out of 1

Detailed Analysis

• 📈 Positive Indicators

  Net Change in Cash: Net Change in Cash increased to 0 million in 2023 from 0 million in 2022 representing a change of 104.75%. Indicating an increased ability to generate cash from the company's operations or its cash flow position.

  Operating Cash Flow: Operating Cash Flow increased to -1 million in 2023 from -2 million in 2022 representing a change of 35.67%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to -1 million in 2023 from -2 million in 2022 representing a change of 37.32%. This indicates an increase in cash generated after accounting for capital expenditures.

  Accounts Payables: The absolute value of Accounts Payables decreased to 0 million in 2023 from 0 million in 2022 representing a change of -61.92%. This indicates that the company has reduced its outstanding obligations to its suppliers.

• 📉 Negative Indicators

  Capital Expenditure: Capital Expenditure increased to 0 million in 2023 from 0 million in 2022 representing a change of 100.0%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

• Quarterly Cashflow Statement

Note: The years below are fiscal years in accounting.

	2024Q2	2024Q1	Q/Q change %
0001463459
operating cash flow	270197	-412398	165.52
free cash flow	270200	-412398	165.52
capital expenditure	3	0	NaN
depreciation and amortization	5000	5000	0.00
deferred income tax	0	0	NaN
stock based compensation	0	0	NaN
accounts receivables	-4033	-73255	94.49
accounts payables	116973	7340	1493.64
inventory	0	0	NaN
acquisitions net	0	0	NaN
investments in property plant and equipment	3	0	NaN
net cash used for investing activites	0	0	NaN
debt repayment	0	0	NaN
common stock issued	0	0	NaN
common stock repurchased	0	0	NaN
dividends paid	0	0	NaN
net cash used provided by financing activities	-317266	434725	-172.98
net change in cash	-47070	22327	-310.82
cash at end of period	123.0	47193	-99.74
cash at beginning of period	47193	24866	89.79

Overall Score of Quarterly Cashflow Statement

0.33 out of 1

Detailed Analysis

• 📉 Negative Indicators

  Net Change in Cash: Net Change in Cash decreased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of -310.82%. Indicating a declined ability to generate cash from the company's operations or its cash flow position.

  Capital Expenditure: Capital Expenditure increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of nan%. This indicates an increase in the cash outflow required for acquiring or improving long-term assets.

  Accounts Payables: The absolute value of Accounts Payables increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 1493.64%. This indicates that the company has increased its outstanding obligations to its suppliers.

  Accounts Receivables: Accounts Receivables increased to 0 in 2024Q2 from 0 million in 2024Q1 representing a change of 94.49%. This suggests that the company is less capable of collecting payments from its customers.

• 📈 Positive Indicators

  Operating Cash Flow: Operating Cash Flow increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 165.52%. This indicates that the company generated more cash from its core business operations.

  Free Cash Flow: Free Cash Flow increased to 0 million in 2024Q2 from 0 million in 2024Q1 representing a change of 165.52%. This indicates an increase in cash generated after accounting for capital expenditures.

Earnings Transcripts ⓘ

No earnings transcripts available.

Earnings Per Share (EPS) ⓘ

Analyst Stock Recommendations ⓘ

Discover detailed analyst recommendations for stocks, including categories such as Buy, Hold, Sell, Strong Buy, and Strong Sell. These insights are based on thorough analysis of financial and market factors. The consensus is calculated by assigning a numerical score to each recommendation. These scores are then weighted and averaged over a specified period to provide a comprehensive view of the stock's outlook, with the final score determining the overall consensus.

Financial Ratios ⓘ

• Annual Financial Ratios

	2023-12-31	2022-12-31	Y/Y change %
FY
calendar year	2023	2022	NaN
revenue per share	0.0	0.0	84.19
net income per share	-0.0	-0.01	49.99
operating cash flow per share	-0.0	-0.01	58.36
free cash flow per share	-0.0	-0.01	59.43
cash per share	0.0	0.0	-33.11
book value per share	-0.01	-0.0	-43.74
tangible book value per share	-0.01	-0.0	-49.00
shareholders equity per share	-0.01	-0.0	-37.85
interest debt per share	0.01	0.01	-13.53
market cap	282077.22	1043404.44	-72.97
enterprise value	2740021.22	2692046.44	1.78
pe ratio	-0.17	-0.5	65.01
price to sales ratio	0.17	1.82	-90.50
pocfratio	-0.23	-0.55	57.98
pfcf ratio	-0.23	-0.54	56.87
pb ratio	-0.12	-0.91	87.30
ptb ratio	-0.12	-0.91	87.30
ev to sales	1.68	4.68	-64.23
enterprise value over ebitda	-1.97	-1.56	-26.68
ev to operating cash flow	-2.25	-1.42	-58.21
ev to free cash flow	-2.25	-1.38	-62.38
earnings yield	-5.77	-2.02	-185.76
free cash flow yield	-4.32	-1.87	-131.85
debt to equity	-1.02	-1.45	29.84
debt to assets	4.65	2.1	121.20
net debt to ebitda	-1.77	-0.95	-85.56
current ratio	0.14	0.34	-59.87
interest coverage	-6.4	-4.86	-31.66
income quality	0.75	0.9	-16.72
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	0.02	0.01	12.87
intangibles to total assets	0.16	0	NaN
capex to operating cash flow	-0.0	-0.03	99.99
capex to revenue	0.0	0.09	-100.00
capex to depreciation	0.0	2.5	-100.00
stock based compensation to revenue	0	0	NaN
graham number	0.02	0.03	-16.97
roic	-10.79	-2.91	-270.56
return on tangible assets	-3.64	-2.67	-36.38
graham net net	-0.01	-0.01	-24.44
working capital	-2489926	-1216941	-104.61
tangible asset value	-2438426	-1059376	-130.18
net current asset value	-2489926	-1216941	-104.61
invested capital	-2353861	-1166941	-101.71
average receivables	125000	125000	0.00
average payables	217537	96551	125.31
average inventory	0	34809	-100.00
days sales outstanding	0	158.8	-100.00
days payables outstanding	153.83	149.86	2.65
days of inventory on hand	0	0	NaN
receivables turnover	0	2.3	-100.00
payables turnover	2.37	2.44	-2.58
inventory turnover	0	0	NaN
roe	0.67	1.84	-63.72
capex per share	0.0	0.0	-100.00

• Neutral

  ROE: Return on Equity (ROE) decreased to 0.67 on 2023-12-31 from 1.84 on 2022-12-31, representing a change of -63.72%. However, ROE is >= 15%, suggesting that the company has been generating high returns for its shareholders still.

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -1.02 on 2023-12-31 from -1.45 on 2022-12-31, representing a change of 29.84%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to -0.17 on 2023-12-31 from -0.50 on 2022-12-31, representing a change of 65.01%. Indicating an increase in the relative valuation of the company's stock.

• Negative

  Current Ratio: Current Ratio decreased to 0.14 on 2023-12-31 from 0.34 on 2022-12-31, representing a change of -59.87%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Quarterly Financial Ratios

	2024-06-30 Q2	2024-03-31 Q1	Q/Q change %
EMGE
calendar year	2024	2024	NaN
revenue per share	-0.0	0.0	-200.00
net income per share	0.0	-0.0	121.91
operating cash flow per share	0.0	-0.0	165.52
free cash flow per share	0.0	-0.0	165.52
cash per share	0.0	0.0	-99.48
book value per share	-0.01	-0.01	-11.86
tangible book value per share	-0.01	-0.01	-14.61
shareholders equity per share	-0.01	-0.01	-11.51
interest debt per share	0.01	0.01	-10.74
market cap	1408938.67	789859.56	78.38
enterprise value	4009084.67	3660201.56	9.53
pe ratio	3.89	-0.48	914.13
price to sales ratio	-3.06	1.71	-278.38
pocfratio	5.21	-1.92	372.26
pfcf ratio	5.21	-1.92	372.25
pb ratio	-0.44	-0.28	-59.97
ptb ratio	-0.44	-0.28	-59.97
ev to sales	-8.7	7.95	-209.53
enterprise value over ebitda	25.83	-10.56	344.49
ev to operating cash flow	14.84	-8.88	267.18
ev to free cash flow	14.84	-8.88	267.18
earnings yield	0.06	-0.52	112.28
free cash flow yield	0.19	-0.52	136.73
debt to equity	-0.82	-1.02	20.07
debt to assets	16.74	4.67	258.14
net debt to ebitda	16.75	-8.28	302.20
current ratio	0.02	0.15	-83.18
interest coverage	2.52	-5.64	144.70
income quality	2.98	1.0	199.03
dividend yield	0	0	NaN
payout ratio	0	0	NaN
sales general and administrative to revenue	0	0	NaN
research and ddevelopement to revenue	-0.01	0.01	-182.74
intangibles to total assets	0.49	0	NaN
capex to operating cash flow	0.0	0	NaN
capex to revenue	-0.0	0	NaN
capex to depreciation	0.0	0	NaN
stock based compensation to revenue	0	0	NaN
graham number	0.01	0.01	-50.57
roic	-0.3	-2.32	86.90
return on tangible assets	1.14	-0.66	272.51
graham net net	-0.01	-0.01	-7.98
working capital	-3170409	-2898710	-9.37
tangible asset value	-3170409	-2766145	-14.61
net current asset value	-3170409	-2898710	-9.37
invested capital	-3094344	-2848710	-8.62
average receivables	75271.5	36627.5	105.51
average payables	319529.5	255222	25.20
average inventory	0	0	NaN
days sales outstanding	-15.1	14.31	-205.51
days payables outstanding	-200.09	136.26	-246.84
days of inventory on hand	0	0	NaN
receivables turnover	-5.96	6.29	-194.78
payables turnover	-0.45	0.66	-168.10
inventory turnover	0	0	NaN
roe	-0.03	0.15	-119.65
capex per share	0.0	0	NaN

• Negative

  ROE: Return on Equity (ROE) decreased to -0.03 on 2024-06-30 Q2 from 0.15 on 2024-03-31 Q1, representing a change of -119.65%. Suggesting that the company has not been generating high returns for its shareholders.

  Current Ratio: Current Ratio decreased to 0.02 on 2024-06-30 Q2 from 0.15 on 2024-03-31 Q1, representing a change of -83.18%. The current ratio has been declining, suggesting a decrease in the company's short-term liquidity. Also, it's below 1, indicating potential liquidity issues.

• Positive

  PE Ratio: Price-to-Earnings (P/E) Ratio increased to 3.89 on 2024-06-30 Q2 from -0.48 on 2024-03-31 Q1, representing a change of 914.13%. Indicating an increase in the relative valuation of the company's stock.

• Neutral

  Debt-to-Equity Ratio: Debt-to-Equity Ratio increased to -0.82 on 2024-06-30 Q2 from -1.02 on 2024-03-31 Q1, representing a change of 20.07%. The debt-to-equity ratio has been increasing, indicating that the company has been relying more on debt financing. Higher leverage may increase financial risk. However, a ratio of 1 or below is often considered healthy and indicates that the company's total debt is equal to or less than its total equity.

Growth Rates ⓘ

• Annual Growth

• Quarterly Growth

Intrinsic Value (Discounted Cash Flow) ⓘ

None